A 52-year-old male from Mumbai with hospital-acquired pneumonia yields a carbapenem-resistant Klebsiella pneumoniae from sputum culture. Which is the most common carbapenem-resistance mechanism in K. pneumoniae in Indian hospitals?

Explanation

## Carbapenem Resistance Mechanisms in K. pneumoniae **Key Point:** Carbapenem-hydrolyzing β-lactamases (carbapenemases) are the most common and clinically significant mechanism of carbapenem resistance in K. pneumoniae, particularly in Indian hospitals where NDM (New Delhi metallo-β-lactamase) is endemic. ### Prevalence of Carbapenem-Resistance Mechanisms | Mechanism | Frequency in K. pneumoniae | Clinical Significance | Examples | |-----------|---------------------------|----------------------|----------| | **Carbapenemase (enzymatic)** | >90% in CR-Kp | Highest; confers resistance to all β-lactams | KPC, NDM, OXA-48, VIM | | **Altered PBPs** | <5% | Rare in K. pneumoniae; more common in P. aeruginosa | Intrinsic resistance | | **Efflux pumps alone** | <2% | Minimal; insufficient for carbapenem resistance | RND family pumps | | **Reduced permeability alone** | <3% | Minimal; usually combined with other mechanisms | OmpK35/36 loss | ### Why Carbapenemases Dominate 1. **Enzymatic hydrolysis:** Carbapenemases (especially serine and metallo-β-lactamases) directly break the β-lactam ring of carbapenems, conferring high-level resistance. 2. **Plasmid-mediated spread:** Carbapenemase genes are located on conjugative plasmids and integrons, enabling rapid horizontal transfer across species and settings. 3. **Indian epidemiology:** NDM-1 (first identified in New Delhi, 2008) is endemic in Indian hospitals and community reservoirs, making it the most common carbapenemase in India [cite:Kumarasamy et al., Lancet Infect Dis 2010]. **High-Yield:** In India, the most common carbapenem-resistant K. pneumoniae (CR-Kp) isolates produce NDM-1 or KPC, not altered PBPs or efflux pumps alone. **Mnemonic:** **ESKAPE** pathogens (Enterococcus, Staphylococcus aureus, Klebsiella, Acinetobacter, Pseudomonas, Enterobacter) are the major multidrug-resistant threats; K. pneumoniae carbapenem resistance is driven by **enzymatic hydrolysis** (carbapenemases), not structural changes. ### Why Other Mechanisms Are Insufficient - **Altered PBPs:** K. pneumoniae has naturally low-affinity PBPs compared to Gram-positive bacteria, but isolated PBP mutations do not confer carbapenem resistance. - **Efflux pumps alone:** Overexpression of RND-type efflux pumps (e.g., AcrAB-TolC) contributes to fluoroquinolone and some β-lactam resistance but is insufficient for carbapenem resistance without additional mechanisms. - **Reduced permeability alone:** Loss of outer membrane porins (OmpK35, OmpK36) reduces carbapenem entry but must be combined with β-lactamase activity or altered PBPs to achieve clinical resistance. **Clinical Pearl:** Carbapenem-resistant K. pneumoniae (CR-Kp) is a major infection control concern in Indian ICUs. Rapid detection of carbapenemase-producing K. pneumoniae (CPKP) is essential for contact precautions and antimicrobial stewardship.